Blum, Kristie A <br/><br/>
Prolonged myelosuppression with clofarabine in the treatment of patients with relapsed or refractory, aggressive non-Hodgkin lymphoma.  [electronic resource] 

 -  Leukemia & lymphoma  Mar 2009 
 - 349-56 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1029-2403 
<br/><br/><label>Standard No.: </label>10.1080/10428190902730227  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adenine Nucleotides--administration & dosage<br/>Aged<br/>Arabinonucleosides--administration & dosage<br/>Clofarabine<br/>Female<br/>Hematopoiesis<br/>Humans<br/>Kinetics<br/>Lymphoma, Large B-Cell, Diffuse--complications<br/>Lymphoma, Mantle-Cell--complications<br/>Lymphoma, Non-Hodgkin--complications<br/>Male<br/>Middle Aged<br/>Myeloablative Agonists--administration & dosage<br/>Neutropenia--chemically induced<br/>Remission Induction<br/>Salvage Therapy--methods<br/>Survival Analysis<br/>Thrombocytopenia--chemically induced